Healthcare Sales & Marketing Network News: loteprednol etabonate

Searching News Database: loteprednol etabonate

HSMN NewsFeed - 2 Apr 2019
Bausch & Lomb Announces the U.S. Launch of LOTEMAX(R) SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment of Postoperative Inflammation and Pain Following Ocular Surgery
Biopharmaceuticals Ophthalmology Surgery Product Launch

HSMN NewsFeed - 20 Mar 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 23 Apr 2014
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 3 Mar 2009
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
Biopharmaceuticals Ophthalmology

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
loteprednol etabonate
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!